Ward 86 Study Evaluates Cabotegravir and Lenacapavir HIV Switch Strategy
New findings out of San Francisco point to an unusual off-label switch strategy involving long-acting cabotegravir plus lenacapavir, a pair of injectables rarely co-prescribed for HIV treatment. In Plain English: ... Read More